Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07572266
Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older AdultsFlorida Institute for Human and Machine CognitionNot Yet RecruitingNot Applicable
NCT07572266Not Yet Recruiting
Not Applicable
Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older AdultsFlorida Institute for Hum...
NCT07572682
Effects of Dynamic Neuromuscular Stabilization (DNS) and Gyrotonic Training on Shoulder Function in Overhead AthletesSport University of TiranaCompletedNot Applicable
NCT07572682Completed
Not Applicable
Effects of Dynamic Neuromuscular Stabilization (DNS) and Gyrotonic Training on S...Sport University of Tiran...
NCT07572357
Clinical Evaluation of the RH210 Hearing AidGlobal Edge Medtech ConsultingNot Yet RecruitingNot Applicable
NCT07572357Not Yet Recruiting
Not Applicable
Clinical Evaluation of the RH210 Hearing AidGlobal Edge Medtech Consu...
NCT07572032
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot StudyAjou University Medical CenterNot Yet RecruitingPhase 4
NCT07572032Not Yet Recruiting
Phase 4
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology...Ajou University Medical C...
NCT07573397
A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal CancerFudan UniversityNot Yet Recruiting
NCT07573397Not Yet Recruiting
—
A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predictin...Fudan University
NCT07572227
Fetal Cystoscopy in the Management of Lower Urinary Tract Obstruction (LUTO)Mayo ClinicEnrolling By InvitationNot Applicable
NCT07572227Enrolling By Invitation
Not Applicable
Fetal Cystoscopy in the Management of Lower Urinary Tract Obstruction (LUTO)Mayo Clinic
NCT07572604
Community Health Worker Assessment for Postpartum HealthEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Not Yet RecruitingNot Applicable
NCT07572604Not Yet Recruiting
Not Applicable
Community Health Worker Assessment for Postpartum HealthEunice Kennedy Shriver Na...
NCT07574372
Effect of ERAS and Upper Limb Exercise on LoS After Modified Radical MastectomyProf. R. D. Kandou General HospitalCompletedNot Applicable
NCT07574372Completed
Not Applicable
Effect of ERAS and Upper Limb Exercise on LoS After Modified Radical MastectomyProf. R. D. Kandou Genera...
NCT07573202
Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh a Randomized Controlled Trial to Evaluate Hypersensitivity Reactions in Shoulder SurgeryThe University of Texas Health Science Center, HoustonNot Yet RecruitingNot Applicable
NCT07573202Not Yet Recruiting
Not Applicable
Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh a Randomized Controlled Trial to...The University of Texas H...
NCT07572097
High-Frequency Irreversible Electroporation vs Standard of Care for Benign Prostatic HyperplasiaShanghai East HospitalNot Yet RecruitingNot Applicable
NCT07572097Not Yet Recruiting
Not Applicable
High-Frequency Irreversible Electroporation vs Standard of Care for Benign Prost...Shanghai East Hospital
NCT07573267
Effects of Myofascial Release, Dynamic and Static Stretching in Adolescent Karate AthletesIstinye UniversityCompletedNot Applicable
NCT07573267Completed
Not Applicable
Effects of Myofascial Release, Dynamic and Static Stretching in Adolescent Karat...Istinye University
NCT07574424
Normative Values For Physical FitnessRiphah International UniversityEnrolling By Invitation
NCT07574424Enrolling By Invitation
—
Normative Values For Physical FitnessRiphah International Univ...
NCT07572383
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive FibrosisNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPhase 2
NCT07572383Recruiting
Phase 2
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibros...National Heart, Lung, and...
NCT07574281
Effectiveness and Implementation of the DINKNESH Digital Palliative Care Tool in EthiopiaAddis Ababa UniversityNot Yet RecruitingNot Applicable
NCT07574281Not Yet Recruiting
Not Applicable
Effectiveness and Implementation of the DINKNESH Digital Palliative Care Tool in...Addis Ababa University
NCT07573059
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated PatientsImmedica Pharma US IncRecruitingNot Applicable
NCT07573059Recruiting
Not Applicable
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Pati...Immedica Pharma US Inc
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07573865
tDCS and Bi-manual Training in Cerebral PalsyKing Fahad Specialist Hospital DammamNot Yet RecruitingNot Applicable
NCT07573865Not Yet Recruiting
Not Applicable
tDCS and Bi-manual Training in Cerebral PalsyKing Fahad Specialist Hos...
NCT07572474
Correlation Between Pinch Grip and Handwriting in School-Age ChildrenOctober 6 UniversityCompleted
NCT07572474Completed
—
Correlation Between Pinch Grip and Handwriting in School-Age ChildrenOctober 6 University
NCT07573332
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica PatientsBristol-Myers SquibbNot Yet RecruitingPhase 1
NCT07573332Not Yet Recruiting
Phase 1
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 An...Bristol-Myers Squibb
NCT07573215
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic AdenocarcinomaRevolution Medicines, Inc.Unknown
NCT07573215Unknown
—
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metast...Revolution Medicines, Inc...
Result Breakdown
Not yet recruiting11 (55%)
Completed4 (20%)
Enrolling by invitation2 (10%)
Recruiting2 (10%)
Unknown1 (5%)
not_applicable13 (65%)
Not Specified4 (20%)
Phase 41 (5%)
Phase 21 (5%)
Phase 11 (5%)